Vericel VCEL
NASDAQ VCEL
$40.19 -0.28 (-0.69%)
As of: Sep 4, 2026 · 3:59 PM EDT

Vericel (VCEL) Short-term Investments (2018 - 2026)

Vericel (VCEL) posted Short-term Investments of $37.1 million for Q2 2026, up 2.93% sequentially from $36.0 million in Q1 2026, and up 2.07% YoY from $36.3 million in Q2 2025.

Analysis

Vericel (VCEL) Short-term Investments (2018 - 2026) Analysis & Trends

Vericel has reported Short-term Investments for 9 years, with the latest figure at $37.1 million in Q2 2026.

  • Quarterly Short-term Investments rose 2.07% year-over-year to $37.1 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $37.1 million (up 2.07% YoY) and the FY2025 annual result came in at $37.4 million, down 10.28% from the prior year.
  • Short-term Investments improved to $37.1 million in Q2 2026 per VCEL's latest filing, from $36.0 million in the prior quarter.
  • Over five years, Short-term Investments peaked at $68.5 million in Q4 2022 and troughed at $35.0 million in Q3 2025.
  • A 5-year average of $45.1 million and a median of $44.8 million in 2022 frame the typical range for Short-term Investments.
  • The sharpest annual moves came in 2022 and 2023: Short-term Investments jumped 95.25% in 2022, then tumbled 40.9% in 2023.
  • Over 5 years, Short-term Investments stood at $68.5 million in 2022, then sank by 40.9% to $40.5 million in 2023, then increased by 3.02% to $41.7 million in 2024, then dropped by 10.28% to $37.4 million in 2025, then retreated by 0.82% to $37.1 million in 2026.
  • According to Business Quant data, Short-term Investments over the past three periods registered $37.1 million, $36.0 million, and $37.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Vericel 2.05 Bn 1.89 Bn 56.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 37.10 Mn
Mar 31, 2026 36.05 Mn
Dec 31, 2025 37.41 Mn
Sep 30, 2025 34.98 Mn
Jun 30, 2025 36.35 Mn
Mar 31, 2025 39.41 Mn
Dec 31, 2024 41.69 Mn
Sep 30, 2024 48.05 Mn
Jun 30, 2024 52.22 Mn
Mar 31, 2024 47.71 Mn
Dec 31, 2023 40.47 Mn
Sep 30, 2023 44.87 Mn
Jun 30, 2023 54.81 Mn
Mar 31, 2023 57.44 Mn
Dec 31, 2022 68.47 Mn
Sep 30, 2022 45.72 Mn
Jun 30, 2022 44.64 Mn
Mar 31, 2022 44.89 Mn
Dec 31, 2021 35.07 Mn
Sep 30, 2021 43.74 Mn